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Abstract
Longitudinal data sources offer new opportunities for the evaluation of sequential
interventions. To adjust for time-dependent confounding in these settings, longitudinal
targeted maximum likelihood based estimation (TMLE), a double-robust method that
can be coupled with machine learning, has been proposed. This paper provides a tutorial
in applying longitudinal TMLE, in contrast to inverse probability of treatment weighting
and g-computation based on iterative conditional expectations. We apply these methods
to estimate the causal effect of nutritional interventions on clinical outcomes of critically
ill children. We estimate the risk of being discharged alive from the pediatric intensive
care unit by a given day, under a range of static and dynamic regimes. We find that
before adjustment, patients who follow the static regime ’never feed’, are discharged
by the end of the 5th day with a probability of 0.88 (95 % CI: 0.87 - 0.90), while for
the patients who follow the regime ’feed from day 3’, the probability of discharge is
0.64 (95% CI: 0.62 0.66). After adjusting for time-dependent confounding, most of this
difference disappears, and the statistical methods provide similar results. TMLE offers
a flexible estimation approach, hence we provide a practical guidance in implementation
to encourage its wider uptake.
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Large, observational databases such as electronic health records are increasingly used to
answer questions of comparative effectiveness. The longitudinal structure of these datasets
allows studies to estimate the effects of interventions that change over time. Examples in-
clude the treatment of chronic diseases such as diabetes and hypertension, where decisions
such as when to initiate a treatment, change the dose or introduce a concomitant medication
are repeatedly updated over time. For decision makers to compare the consequences of alter-
native longitudinal interventions, it is essential to carefully define the strategies of interest
(1). A static regime for time-varying interventions pre-specifies the full sequence of interven-
tions, irrespective of changing patient characteristics over time (for example: ‘always treat’).
Dynamic regimes, or individualized treatment rules, in contrast, define a set of rules as a
function of time-varying patient charact ristics (2; 3; 4; 5; 6). While sequentially randomized
trials provide an ideal design for the evaluation of dynamic regimes (7; 8) such trials are still
relatively rare (9), and are impractical for many clinical and health policy questions (10).
Where the only available data for estimating the treatment effects of interest are from
observational studies, statistical methods are required to address both baseline and time-
dependent confounding. The latter arises in longitudinal settings, when the uptake of treat-
ment may depend on factors that influence the outcome and are also affected by earlier
treatments. It is widely recognized that standard regression analysis cannot deal with time-
dependent confounding (2; 11). While in the last decades progress has been made in de-
veloping appropriate statistical methods for addressing time-varying confounding (see (12)
for a review), applications of these approaches have been confined to relatively few clinical
areas, such as human immunodeficiency virus infection (13). Further methodological and
applied research is required that demonstrates these approaches for handling time-varying
5
Page 5 of 51 American Journal of Epidemiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
confounding, in different contexts.
Inverse probability of treatment weighting (IPTW) (14; 11), a simple and intuitive method
for estimating the effect of time-varying treatments, results in unstable and biased estimates,
in the presence of data sparsity, even when weights are normalized and extreme weights
are truncated (15). A commonly used alternative approach, parametric g-computation (2)
requires parametric specification of multiple aspects of the data distribution, including models
for the full conditional densities (or probability distributions) of the outcome and of the time-
dependent confounders given the past. Similarly, structural nested mean models require a
parametric model for the treatment effect, the ‘blip function’ (16). A perennial concern with
these approaches is that they are prone to model misspecification, leading to biased estimates
of treatment effects.
Targeted learning (17) has been proposed as a general approach for causal inference prob-
lems with both time-constant, and time-varying interventions to estimate a range of causal
parameters (18; 19; 20; 21; 22). Targeted learning encompasses a semi-parametric, double-
robust estimation approach, targeted maximum likelihood estimation (TMLE) (17) for single
time point and longitudinal causal effects. TMLE combines estimates of the treatment and
outcome mechanism, and provides a consistent estimator of the target parameter if either
the treatment or the outcome mechanism are estimated consistently. If both are estimated
consistently, TMLE is efficient (19). In order to reduce bias, achieve efficiency, and ensure
accurate statistical inference, TMLE is often coupled with machine learning, in particular the
Super Learner, a cross-validation based estimator selection approach (23; 24). For a tutorial
for single time-point interventions, see for example (25).
This paper demonstrates the application of the longitudinal TMLE estimator based on
6
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iterative conditional expectations (26; 21), and highlights how it is related to the IPTW
(11) and g-computation (2; 26) estimators. While prior studies exist demonstrating the
application of this estimator in longitudinal settings (26; 22; 27; 28; 29; 30) few observational
data applications have discussed the use of the estimator to study the effects of dynamic
regimes, or subject responsive adaptive treatment strategies (31).
We apply IPTW, g-computation based on iterative conditional expectations and longitu-
dinal TMLE to an empirical study investigating an unanswered question of high relevance
to clinical decision-makers: what is the optimal timing and quantity of caloric intake for
critically ill children? We re-analyze the “Control of Hyperglycemia in Paediatric Intensive
Care” (CHIP) clinical trial (32), to estimate the effect of alternative treatment regimes on the
probability of being discharged from the Paediatric Intensive Care Unit (PICU) by a given
day, under a range of clinically relevant treatment regimes. We follow the general targeted
estimation roadmap (33) to formulate the hypothetical regimes, define the causal parameters
of interest, and discuss how to identify, estimate and interpret these parameters.
METHODS
Research question in the CHIP study
An important objective of critical care medicine is to provide the appropriate level of nu-
tritional support over the course of the patient’s stay. In most critical care settings, the
preferred mode of nutritional support is via the nasogastric (enteral) tube, which is often
complemented with intravenous (parenteral) feeding. For adult patients admitted to critical
care, evidence-based guidelines exist, and recent randomized controlled trials have reported
7
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that nutrition started early after admission to the PICU favorably alters outcomes (34). For
critically ill children, guidelines for nutritional support are limited by the lack of available
evidence (35). While a recent randomized trial of nutritional support for children admitted
to the PICU (36) found that delaying parenteral nutrition led to favorable clinical outcomes,
there is no randomized trial evidence to address more complex but important questions, such
as what is the optimal timing and total quantity of nutritional support for children admitted
to the PICU.
The recently published CHIP randomized trial, undertaken at 13 centers in England,
with 1369 participants (recruited between 2008 and 2011, aged 0 to 16 years) found that
tight glycemic control in critically ill children has no effect on the primary clinical outcome,
the number of ventilator-free days (32). We undertake a secondary analysis of the CHIP
dataset to investigate the causal effect of different levels of nutritional support on a clinical
outcome. We focus on the subgroup who were admitted to the PICU to undergo cardiac
surgery, and were younger than three years of age.
We follow the National Academy of Medicine (formerly Institute of Medicine) guidelines
(37) in standardizing individual caloric intake by dividing the individual measures of daily
intake by a target level, specific to the patient’s gender, age, height and weight. We define a
patient as ‘fed’ on a given day if he or she receives at least 20% of the individualized target.
The outcome of interest is being discharged alive from the PICU to other hospital wards by
a given day.
The effect of the feeding strategy on a given day on the patient’s discharge status is subject
to potential confounding from baseline characteristics such as age, sex, weight, height and the
Risk Adjusted classification for Congenital Heart Surgery (RACHS-1) risk score, expressing
8
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severity at admission (38), and the randomization arm (tight or standard glycemic control).
Younger children, and those with higher risk scores tend to be fed less aggressively, and are
also likely to stay longer in the PICU, potentially biasing the effect of feeding compared to no
feeding towards a seemingly protective effect. While all patients are mechanically ventilated
at baseline, being taken off mechanical ventilation is a strong predictor of discharge on the
next days. Patients just taken off mechanical ventilation can, for safety reasons, be fed only
through the parenteral (and not the enteral) route, making it less likely that their caloric
intake reaches the 20 % threshold. Hence, a lack of adjustment for mechanical ventilation
status could make no feeding appear beneficial. Further time-varying potential confounders
include renal replacement therapy, infection, and a vasoactive inotrope score (39).
Observed data structure
For each patient, the level of calorific intake (the treatment) was measured daily from study
entry (randomization) until the relevant clinical outcome was recorded (discharge from the
PICU, or death while in the PICU). We restrict the follow-up data used in this analysis to
the first seven days post randomization as the majority of patients were discharged from the
PICU by this time point. We denote time by t = 0, ..., T + 1, where T + 1 = 7 is the end
of follow-up. At each time point, the patient’s feeding status is represented by the binary
variable At, while confounders are denoted by the multi-dimensional variable Zt. The first
measurement of the time-varying confounders and the vector of baseline confounders are
jointly denoted with Z0. Mechanical ventilation, renal replacement therapy, infection and
randomization arm are binary variables, while the RACHS-1 and vasoactive inotrope scores,
weight, height and age are continuous.
9
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Mt and Yt indicate whether by the end of time period t, a patient has died (Mt = 1), or has
been discharged alive from the PICU (Yt = 1). We use overbars to denote histories, e.g., treat-
ment history is denoted by At = (A0, ..., At). We assume that the observed data are n inde-
pendent and identically distributed copies of O = (Z0, A0, Y1,M1, Z1, A1, ..., AT , YT+1) ∼ Po,
where Po is the true underlying distribution from which the data are drawn, and where, for
notational convenience, we assume that variables after death or discharge are deterministi-
cally equal to their last observed values. The ordering of the elements of O represent their
assumed causal ordering. For example, the baseline covariates (Z0) precede the first instance
of feeding (A0), which precedes whether the patient is discharged by the end of the first day
(Y1).
We denote the history of the confounders, discharge status and death with a single vector
Lt = (Zt, Y t,M t) that will be referred to as ‘covariates’. Death is treated as a competing
event for PICU discharge: if Mt = 1, then any subsequent Yt′ = 0 for t
′
> t.
Formulating the interventions of interest
We consider two types of longitudinal interventions: static and dynamic treatment regimes.
Let the vector a = (a0, a1, ..., aT ) denote a longitudinal feeding regime, defined up to the
last period before the end of follow-up. The elements of this vector, at define the feeding
intervention, with static and dynamic regimes differing in how at is specified. For a static
regime, at is a pre-specified constant for each t. For example, the static regime ‘never feed’,
sets at to 0 in each t, resulting in the treatment regime a = (0, 0, ..., 0), while the static regime
‘feed from day 3’, would be defined as a = (0, 0, 1, ..., 1).
For dynamic regimes, at is set by a decision rule. We define dt as a function that incor-
10
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porates information available on a subject up to time t, such as some subset of the covariate
history, denoted V¯t. We use d(V t) to denote the vector of interventions required by regime
d from time 0 to time t, given the realized covariate history. Here, we specify a dynamic
treatment regime in which clinicians are required to feed a patient on each day that he or
she is not mechanically ventilated (Zt,1 = 1).)
Clinical guidelines may not require the intervention to start on the first day, and could
allow delaying the start of the intervention. For example, the regime ’feed by the third day’
leaves the treatment values to be random for 2 days, then requires feeding from day 3. This
regime is denoted by a¯2:T = (A0, A1, 1, ..., 1), where A0 and A1 are the observed levels of
feeding on the first two days.
Throughout we consider regimes that implicitly only assign a feeding intervention up till
time of discharge or death. Thus a subject who followed a regime of interest up to death
or discharge, according to our definition, continues to follow this regime up to time T + 1.
To simplify notation, in the sections that follow, we refer to the counterfactual interventions
generally as d = (d0, ..., dT ) ∈ D, where D is the set of regimes of interest, and note that this
notation includes static regimes as special cases of dynamic regimes.
Target causal parameter and identifying assumptions
The counterfactual discharge status at time period t that would have been observed under a
given feeding regime d is denoted by Y dt . Our causal parameter of interest is the intervention-
specific mean outcome, the expected discharge status by a selected time t∗, under a given
regime d, where t∗ = 1, ..., T + 1:
ψd,t∗ = E[Y
d
t∗ ].
11
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ψd,t∗ can be interpreted as the counterfactual cumulative risk of discharge by day t
∗ if all
subjects had followed a given regime.
In order to identify ψd,t∗ from the observed data, the following assumptions are required
(2):
The sequential randomization assumption states that, conditional on the observed
treatment and confounder history, the potential outcome is independent of treatment status
in each preceding time period,
Y dt∗ ⊥ At|Lt, At−1 = d(V¯t−1),
for t = 0, ..., t∗ − 1, and d ∈ D. This assumption requires that a sufficiently rich set of
confounders are measured, so that it can be assumed that conditional on observed covariates,
and following the regime of interest, the feeding decision at time t is ‘at random’.
The positivity assumption requires that for each feeding regime d, in each period t
before the final time period of interest t∗, patients must have a positive probability to follow
that regime, conditional on having followed it up to that time point, for any combination of
observed covariate history:
Pr[At = d(V t)|Lt, At−1 = d(V t−1)] > 0,
for t = 0, ..., t∗ − 1.
Estimation
This section describes the IPTW estimator, the g-computation and longitudinal TMLE esti-
mators, for interventions starting on the first day. For interventions with a delayed start, we
provide small modifications of the estimators in the Web Appendix 2.
12
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Inverse probability of treatment weighting
IPTW estimates the intervention-specific mean of a treatment regime by re-weighting the
observed outcomes of the subset of the study sample who followed the regime (11). We
denote the probability of a subject following a regime of interest dt at time t, given her
covariate and treatment history with
gt = Pr[At = dt(Vt)|At−1 = d(V t−1), L¯t],
and the cumulative conditional probability of following regime d through time t∗ − 1 as:
g0:t∗−1 =
t∗−1∏
t=0
gt.
The stabilized Horvitz-Thompson IPTW estimator (14; 40) of the cumulative risk of
discharge by period t∗ under treatment regime d is based on estimating the following quantity:
E(Yt∗ × I(A¯t∗−1 = d(V¯t∗−1)/g0:t∗−1)/E(Yt∗ × I(A¯t∗−1 = d(V¯t∗−1)/g0:t∗−1),
where I(At∗−1 = d(V t∗−1)) indicates whether a patient has followed the treatment regime
d up to one before the final period of interest. Implementation is based on estimating gt for
t = 0, ..., t∗− 1, plugging in these estimates, and taking the empirical mean of the numerator
and denominator.
Drawbacks of the IPTW estimator include reliance on consistent estimation of the treat-
ment mechanism, as well as susceptibility to violations and near violations of the positivity
assumption, resulting in unstable estimates (see for example (15)). The next section de-
scribes the longitudinal targeted maximum likelihood estimator, a double-robust estimator
which can improve on the properties of the IPTW estimator by using information not only
13
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on the treatment mechanism, but also on the outcome-confounders relationship.
The longitudinal targeted maximum likelihood estimator
The conditional expectation representation of the g-computation formula
The longitudinal TMLE (21) uses the identifiability result established by the g-computation
formula (2). In short, the g-computation formula expresses the intervention-specific mean as
a function of the conditional distributions of the outcome, and the time-varying confounders,
given the past among subjects who followed the regime of interest. For discrete-valued
confounders, this can be written as follows:
E[Y dt∗ ] =
∑
lt∗−1
E[Yt∗ |At∗−1 = d(vt∗−1), Lt∗−1 = lt∗−1]
∏t∗−1
t=0 Pr(Lt = lt|At−1 = d(vt−1), Lt−1 =
lt−1), where the summation is taken over all possible values lt∗−1 of the confounder history.
Intuitively, the g-computation formula estimates the conditional expectation of the outcome
under the treatment regime of interest, and averages these expectations over the intervened-
on distribution of the confounders, i.e. the distribution that the confounders would take
under the treatment regime of interest. Parametric g-computation (2; 41; 42) estimates the
components of this formula directly, and makes strong parametric assumptions due to the
need to specify conditional densities or probabilities for each of the time-varying confounders
(12; 43).
The g-computation formula can be re-written as a series of iterated conditional expecta-
tions of the observed outcome (44; 45; 26):
14
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E[Y dt∗ ] = E
[
...E
[
E
[
E
[
Yt∗ |At∗−1 = d(V t∗−1), Lt∗−1
]
|At∗−2 = d(V t∗−2), Lt∗−2
]
|At∗−3 = d(V t∗−3), Lt∗−3
]
...
]
, (1)
where the innermost expectation is the conditional distribution of the outcome, given the
full treatment and confounder history, evaluated at the treatment values that would have
been assigned according to the intervention of interest d. The second innermost expectation
marginalizes over the intervened-on history of Lt∗−1, the next one over Lt∗−2, and so on,
until the last expectation is taken over the empirical distribution of baseline confounders L0,
where M0 = 0 and Y0 = 0. We first briefly review how to obtain the target parameter using
these iterative regressions, then describe how the longitudinal TMLE extends this approach.
Steps of g-computation using sequential regressions
Step 1: Regress the outcome on full treatment and confounder history
First the innermost expectation of Equation 1 is estimated: E[Yt∗ |Lt∗−1, At∗−1 = d(V t∗−1)].
We will refer to this quantity as Qt∗ . This expectation can be estimated by regressing the
outcome on past covariates and treatment variables, for example using a logistic regression,
and taking predictions at the treatment values corresponding to the intervention of interest.
Step 2: Take the previous predictions as the new outcome, regress on history
up to t∗ − 2.
The predictions from the previous step, Qt∗ are now taken as the new outcome, and
are regressed on confounders and treatment variables up to time period t∗ − 2. As before,
15
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predictions are generated for treatment values required by the regime d, up to time period
t∗−2. This expectation, Qt∗−1, corresponds to the second innermost expectation in Equation
1. Qt∗−1 is marginal over the intervened-on distribution of the time varying confounder Lt∗−1,
but conditional on the time varying confounders up to time period Lt∗−2.
Steps 3, Step 4,..., to Step t∗: Iterate Step 2
Step 3 takes the predictions from Step 2, Qt∗−1 and regresses them on the treatment and
confounder history up to t∗ − 3, then takes predictions as described above, stored as Qt∗−2.
This step is iterated until the last step, where the expectation is only conditional on the
baseline covariates: Q1 = E[Q2|L0, A0 = d(V0)].
Step t∗ + 1: Average over the empirical distribution of the baseline covariates
By averaging Q1 over the empirical distribution of the L0, the g-computation estimator
for the intervention-specific mean is obtained as Q0 = E[Q1].
Each Qt can be obtained using a regression, for example a linear or logistic regression.
This approach offers substantial advantages over the parametric g-computation approach,
by avoiding the need to estimate the conditional density of each time-varying confounder.
However, estimating these iterative regressions well can be challenging and the approach
remains susceptible to bias due to misspecification. Bang and Robins (26) propose a double
robust and semiparametric efficient version of this sequential regression estimator based on
including an additional, ‘clever’ covariate that uses information from the treatment assign-
ment mechanism. Joffe (46) subsequently suggested moving this clever covariate to a weight,
an approach that improved performance in the face of practical positivity violations. The
resulting estimator is double robust in the sense that if either the treatment mechanisms or
the sequential regressions are estimated consistently, then the estimator is consistent. If both
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are estimated consistently, it is efficient in a semiparameteric model that makes assumptions,
if any, only on the treatment mechanism (26). Van der Laan and Gruber (21) subseqently
placed this estimator in the general TMLE framework. The general idea behind this TMLE is
that it is a two-step estimator: first, the conditional expectation of the outcome is estimated,
then, this estimate is updated using information from the treatment assignment mechanism,
targeted in a way that it reduces bias for the parameter of interest. Longitudinal TMLE
performs the update step at each stage of the sequential regressions, as we summarize below.
The update step of the TMLE estimator
Qt∗ is defined and estimated as in Step 1 of the g-computation approach. This initial estimate
is then updated, by perturbing the initial fit Qt∗ using a parametric submodel, defined as
logit(Q
1
t∗(ǫt∗)) = logit(Qt∗) + ǫt∗ . We estimate ǫt∗ by fitting a logistic regression of Yt∗ on
the intercept, using the prior predicted value of Qt∗ as offset, and weights corresponding to
I(A¯t∗−1 = d(V¯t∗−1))/g0:t∗−1, an indicator of whether a subject has followed the regime of
interest up to the previous time period divided by the predicted probability of having done
so. The estimated ǫt∗ is then used to update the initial estimate, which is stored as Q
1
t∗ , and
will be used as the new outcome for the next iteration.
This update is performed after each step of the sequential regressions, described for the
g-computation estimator. The regression and update steps are iterated until the last step, in
which the updated expectation Q
1
1 is only conditional on the baseline covariates. Analogous
with the last step of the g-computation estimator, the TMLE estimator for the intervention-
specific mean is obtained as Q
1
0 = E[Q
1
1].
The consistency of the estimator relies on the consistent estimation of either the treatment
17
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mechanism or the iterated conditional regressions while its efficiency relies on consistent
estimation of both. In practice, often both components are expected to be misspecified,
when fixed, parametric models such as logistic regressions are used. Machine learning or
data adaptive approaches are thus advocated to estimate both. (19). We use the Super
Learner (47), a machine learning algorithm that uses cross validation to find the optimal
weighted convex combination of multiple candidate prediction algorithms, for estimating
both the treatment assignment mechanism, as well as the sequential regressions (See the
Web Appendix 3 for more details).
Implementation
We implement the IPTW, g-computation and TMLE estimators described above to estimate
the cumulative probability of PICU discharge by the end of days 1-7, under a range of pre-
specified static treatment regimes: never feed, feed from day 1,2,3,.. to 7, static regimes
over limited time periods: feed by day 2,3,.. to 7, and the dynamic regime ‘feed when off
ventilation’.
We use the Super Leaner to estimate the treatment assignment mechanism and the se-
quential regressions, and use these models to construct the three estimators. Among the
Super Learner candidates, we included an intercept model, a main terms and a logistic
regression model with all possible two-way interactions in the linear predictor, a stepwise lo-
gistic regression, generalised additive models (48), a Bayesian generalized linear model with
main terms in the linear predictor (49), lasso (50), boosting (51) and neural networks (52).
We specified a 10-folds cross validation (47). We estimate separate models for the treat-
ment assignment mechanism for each period, while assuming that treatment decisions are
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influenced only by treatment and confounder values in the two most recent periods. The
regressions to obtain the conditional probability of treatment and the iterative regressions
and the update steps of the TMLE are only run among those who remain alive and not
discharged. We contrast these estimates to ‘naive’ estimates, taken as the simple proportion
of discharge status among those who follow a given regime.
The 95% confidence intervals are based on an estimate of the empirical influence function
(53; 54) of the IPTW and TMLE estimators. For the g-computation estimator, no influ-
ence function based approach for inference is readily available, and the point estimates are
reported without 95% confidence intervals. While the non-parametric bootstrap represents
an alternative approach to variance estimation, when Super Learner is used to estimate the
sequential regressions without subsequ nt targeting, bootstrapping can impose substantial
computational burden while still failing to provide valid inference. The availability of an in-
fluence curve based variance estimator compatible with machine learning approaches is thus
an additional attractive feature of the TMLE. The methods are implemented using the ltmle
R package Version 0.9-9 (55; 56), which incorporates the Super Learner R package (57). We
provide the main R functions used for the analysis in the Web Appendix 4.
RESULTS
706 children were included in the study sample. The number of patients who were still in
the PICU at each time point, and among those, the number of patients receiving less than
20% of their daily caloric target (not fed), and those receiving at least 20% (fed) is reported
in Table 1. Table 2 shows patient numbers observed to have followed each static regime of
interest, up to a given day. Figure 1 contrasts the static regimes ‘never feed’, and ‘feed from
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day 3’, reporting the naive estimates, not adjusted for any observed confounders (Figure 1
A), and the IPTW (Figure 1 B) , g-computation (Figure 1 C) and TMLE estimates (Figure1
D). See Web Table 1 in the Appendix, for illustrative calculation of the naive estimates for
patients who followed the regime ‘feed from day 3’.
The naive estimates indicate a significantly higher probability of being discharged by each
day, for the ‘never feed’ regime, compared to the ‘feed from day 3’ regime. For example, the
probability of discharge by the end of day 5 is 0.88 (95% CI: 0.87 - 0.90) for ‘never feed’, in
contrast to the significantly lower estimate of 0.64 (95% CI: 0.62 - 0.66) for ‘feed from day
3’. Adjustment for baseline and time-varying confounders shifts the estimated probability
of discharge at each time period downwards, and reduces the difference between the two
regimes. Using TMLE we estimate a 0.66 probability of discharge by the end of day 5 for
those who were never fed (95 % CI: 0.59 - 0.72), and a 0.53 probability for those who were
fed from day 3 (95% CI: 0.48 - 0.59). The TMLE, IPTW and g-computation estimators
report similar point estimates, while the TMLE reported narrower 95% CIs compared to
the IPTW estimator. For example, the probability of discharge by the end of day 5 for the
‘feed from day 3’ regime was estimated to be 0.54 (0.47 - 0.60) using IPTW, and 0.59 using
g-computation. The smallest estimated cumulative probability of following a given regime,
across all regimes considered was > 0.05, so no weight truncation was used.
Focusing on the cumulative probability of discharge by day 4, Figure 2 contrasts the
intervention-specific mean estimates across all regimes distinguishable by this time point,
estimated by TMLE. The estimated probability of the static regime "feed from day 1" is
0.42, with the widest 95% CI among all regimes (0.21 - 0.62), which can be explained by
the low number of patients following this regime. Regimes requiring starting feeding from or
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by the third day, compared to starting on the second day, have lower expected probability
of discharge; however, the 95% CIs overlap. As before, the regime ‘never feed’ has the
most favorable expected outcomes (TMLE reporting an estimated probability of discharge of
0.63 (95% CI: 0.57 - 0.79); however, the probability of discharge under this regime was not
statistically significantly different from the other regimes.
DISCUSSION
We implemented a double-robust approach, targeted maximum likelihood estimation, to con-
trast the counterfactual probability of being discharged alive from the PICU under a set of
static and dynamic longitudinal feeding regimes, in a population of critically ill children.
While the unadjusted estimates show a significant difference in discharge probabilities be-
tween the treatment regimes ‘start feeding from the 3rd day’, compared to ‘never feed’ , after
adjustment, most of this difference disappears. TMLE estimators report narrower confidence
intervals than IPTW, as predicted by theory (17), while influence curve based confidence in-
tervals for g-computation estimators are not readily available. We found no strong evidence
that high levels of caloric intake may lead to adverse health outcomes in critically ill children.
While in this paper the three statistical approaches led to similar conclusions, depending on
the setting, TMLE may give substantially different results from estimation methods that
are not double-robust, or don’t exploit data-adaptive model selection (see e.g. (27) for an
application, and (28) for simulation evidence).
An observational analysis of data from a clinical trial enabled us to investigate the impact
of alternative longitudinal feeding practices on clinical outcomes. We contributed to the
literature of applying longitudinal causal methods in the PICU setting, where, due to the
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fast changing prognosis of patients, and subsequently updated treatment decisions, time-
dependent confounding is an important concern (58). Using clinical judgement on meaningful
longitudinal treatment regimes, we selected a range of static and dynamic interventions which
were supported by the data, and asked new causal questions. While data collected in a clinical
trial can provide advantages, such as regular intervals of follow-up, measurement of a rich
set of observed and time-varying confounders, and little missing data, the approach taken
generalizes to settings of observational data.
The paper further provides a demonstration of the application of TMLE for longitudinal
static and dynamic regimes, and highlights how it builds on alternative approaches such as
IPTW and g-computation, under the challenging circumstances of a real-world comparative
effectiveness study: large number of covariates to adjust for, and a medium sized sample.
Application of the methods to address an unanswered clinical question of high relevance in
intensive care raised several methodological issues. Beyond static and dynamic treatment
regimes, we also considered interventions with a delayed start, for example “feed by day
3”, motivated by clinical practice. The availability of daily measurements of time-varying
confounders resulted in high dimensionality of observed covariates to adjust for. Informed by
clinical judgement, we assumed that the decision on whether to feed on a given day is only
influenced by observed characteristics measured on the given and on the previous day. To
deal with the challenge of model specification, we used the data-adaptive algorithm, Super
Learning.
Each of the methods applied here relies on the assumption that in each period, all time-
constant and time-varying confounders that can influence treatment assignment and the
outcome were observed. While the CHIP trial recorded a rich set of covariates, patients’
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prognosis changes quickly over time, and the observed time-varying characteristics (mechan-
ical ventilation, renal replacement, inotrope score) may not capture all confounders. In
particular, if a clinician expects a patient to be discharged from the PICU soon, she may
temporarily decrease, or not initiate enteral feeding, to prevent delay in discharge. Further
research using methods to analyse the sensitivity of the parameter estimates to the presence
of unobserved confounders is therefore warranted (59).
In summary, this paper illustrates that existing data sources such as well-conducted ran-
domized controlled trials can be exploited, to address important questions of clinical decision
making, beyond those originally posed. A wider use of appropriate causal methods could
add to the understanding of the advantage of alternative sequencing of time-varying treat-
ments, and provide estimates of the effectiveness and cost-effectiveness of realistic treatment
strategies.
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TABLES AND FIGURES
Table 1: Patient flow in the CHIP study, by treatment status and outcomes, on each hospital day
Hosp day In PICU In PICU, fed In PICU, not fed Cumulative dead Cumulative discharged
1 706 28 678 0 0
2 701 260 441 0 5
3 597 387 210 0 109
4 434 340 94 0 272
5 325 278 47 3 378
6 248 222 26 5 453
7 188 169 19 7 511
PICU: pediatric intensive care unit
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Table 2: Cumulative number of patients whose data are consistent with each static
regime
Feed from.. Never feed
Hosp day Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
1 28 678 678 678 678 678 678 678
2 24 241 442 442 442 442 442 442
3 24 220 254 270 270 270 270 270
4 22 212 237 205 197 197 197 197
5 21 205 232 195 178 173 173 173
6 21 202 226 192 176 165 165 165
7 21 200 223 186 175 164 163 162
Hosp: hospital
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Figure 1: Estimated cumulative probabilities of discharge by end of days 1 to 7, for the
regimes ‘never feed’ vs. ‘feed from day 3’
Part A: Unadjusted estimates and 95 % CIs; Part B: IPTW estimates and 95 % CIs, Part C: G-computation
estimates; Part D: TMLE estimates and 95 % CIs. The x axis displays days, while the y axis displays the
estimated counterfactual probability of discharge from PICU, by the end of a given day, for a given regime.
The triangle marker stands for the regime ‘never feed’ (corresponding 95 % CIs displayed with dashed lines),
while the circle marker displayes the regime ‘feed from day 3’ (corresponding 95 % CIs displayed with solid
lines). The 95 % CIs of the g-computation estimates are not reported.
Figure 2: Estimated cumulative probabilities of discharge by end of day 4
The x axis displays the regimes compared, while the y axis displays the TMLE estimates and correspondig
95 % CIs of the counterfactual probabilities of discharge from PICU, by the end of day 4, for a given regime.
Abbreviations of regimes compared: From Day 1: Feed from day 1, From Day 2: Feed from day 2, By Day
2: Feed by day 2, From Day 3: Feed from day 3,..., Never: never feed, Dynamic: feed when off mechanical
ventilation
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Web Appendix 1
Causal model
We assume the following nonparametric structural equation model, M:
Yt = fYt(Y t−1,M t−1, Zt−1, At−1, UYt), for t = 1, ..., T + 1
Mt = fMt(Y t,M t−1, Zt−1, At−1, UMt), for t = 1, ..., T
Zt = fZt(Y t,M t, Zt−1, At−1, UZt), for t = 0, ..., T
At = fAt(Y t,M t, Zt, At−1, UAt), for t = 0, ..., T ,
where Ut = (UYt , UMt , UZt and UAt), t = 0, ..., T + 1 are unmeasured exogenous random
variables from some underlying probability distribution PU . This causal model specifies how
each of the variables in the data are generated, with randomness arising only from from the
exogenous variables U . For example, the outcome at a given time period, Yt is a deterministic
function of the full history of treatment and confounder values, and a random error. Yt and
Mt are also functions of previous values of Y and M , encoding the information that after
a patient is discharged, she always remains discharged, but if a patient dies in a given time
period, she remains dead, and can never be discharged. More generally, after an event of
death or discharge, all the processes become degenerate, and for notational convenience we
assume that they take the last value observed. For notat onal convenience the causal model
allows for Y0, and M0, which are both assumed to take value 0 (at baseline no one is dead or
discharged), and Z−1, A−1 which are assumed to be empty vectors.
∗corresponding author details: Noemi Kreif, Centre for Health Economics, University of York, Heslington,
York, YO10 5DD, UK. Tel: work +44 (0)1904 321401 e-mail: noemi.kreif@york.ac.uk.
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Web Appendix 2
Modification of the estimators for the static regimes with delayed start
For regimes where the intervention starts with a delay, such as ‘feed by day k’, corresponding
to an intervention beginning at t = k − 1, the At nodes denoting feeding prior to time k − 1
are treated as non-intervention nodes or ‘covariates’. As a result, the baseline covariates
(measured prior to the first intervention node Ak−1) consist of
(Z0, A0, ..., Yk−1,Mk−1, Zk−1).
When estimating E[Y d
t∗
], t∗ = k, ..., T + 1, there are thus a total of t∗ − (k − 1) rather than
t∗ intervention nodes, and a corresponding number of components to the regimes of interest
(d(V¯t) = dk−1(V¯k−1), ..., dt∗−1(V¯t∗−1)).
The IPTW, g-computation, and TMLE estimators are modified accordingly. First, the
indicator of following a regime of interest through time t∗−1, I(A¯t∗−1 = d(V¯t∗−1)), used in the
numerator of the weights for the IPTW and TMLE estimators, corresponds to an indicator
of following the regime from time k − 1 to t∗ − 1. (In other words, all subjects follow the
regime of interest before k − 1). Second, the cumulative probability of following the regime
of interest, used in the denominator of the weights for the IPTW and TMLE estimators, is
now based on a product of time point-specific probabilities of continuing to follow the regime
beginning at time k − 1:
gk−1:t∗−1 =
t∗−1∏
t=k−1
gt(At = dt(V¯t)|A¯t−1 = d(V¯t−1), L¯t).
Finally, the presence of fewer intervention nodes implies that the longitudinal g-formula
can be expressed using t∗ − (k − 1) rather than t∗ iterated conditional expectations; one
conditional expectation is needed for each intervention node. Thus implementation of the
sequential regression g-computation and TMLE estimators requires fitting fewer conditional
3
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regressions.
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Web Appendix 3
Super Learning estimation of the treatment and outcome mechanism
The Super Learner (1) is a machine learning algorithm that uses cross validation to find the
optimal weighted convex combination of multiple candidate prediction algorithms. The algo-
rithms are pre-selected by the analyst, potentially including parametric and non-parametric
regression models, as well as a range of machine learning approaches. Asymptotically, the
Super Learner algorithm performs as well as the best possible combination of the candidate
estimators, assuming that none of the candidates in the library is a correctly specified para-
metric model; in the latter case it achieves almost parametric rate of converge (see (2) and
(3) for details). Beyond its use for prediction (4; 5), it has been used for estimating the
propensity score and the outcome model to obtain causal parameters (for example, (6; 7; 8)),
and has been shown to reduce bias from model misspecification (9; 10; 11).
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Web Table 1: Patient flow and unadjusted estimates: regime ‘feed from day 3’
Hosp day In PICU (t) In PICU Dischg Death Stops Cum. Cum. Prob dischg
& follows (t)) event (t+1) (t+1) following (t+1) follows (t) discharge (t) by t+1 |follows t
1 706 678 5 0 236 678 5 0.007
2 701 437 77 0 265 442 82 0.186
3 597 172 23 0 17 254 105 0.413
4 434 132 33 0 5 237 138 0.582
5 325 94 10 0 6 232 148 0.638
6 248 78 21 0 3 226 169 0.748
7 188 54 11 0 0 223 180 0.807
Cumulative discharge is calculated amongst those whole followed the rule. The last column corresponds
the unadjusted estimates reported in Figure 1.
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Web Appendix 4
Main R functions used in the analysis
##### deterministic Q function #############################
# objective: set Q to 1 deterministically if any prior L2=1
my.det.Q.fun <- function(data, current.node, nodes, called.from.estimate.g) {
dnodes <- grep("L2", names(data))
if (! any(dnodes < current.node)) { # outputs FALSE if there is no death node
before currnt Anode
return(NULL)
}
dnodes <- dnodes[dnodes < current.node] # only look at death nodes before current
node
dnodes.is1 <- data[, dnodes, drop=FALSE] == 1 & !is.na(data[, dnodes, drop=FALSE
]) # true if dnode is 1 (and not NA)
dead <- apply(dnodes.is1, 1, any)
return(list(is.deterministic=dead, Q.value=0))
}
#### MAIN FUNCTION ACTUALLY CALLING TMLE, it takes different arguments for
different kinds of interventions
#### It calculates iptw, tmlw and gcomp, for 2 interventions. One is never feed (
static), this stays fixed, I call it control.
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#### The other one is a "treatment" regime, either static, or with delayed
intervention ( v ) needs to be specifed, or dynamic.
#### Dynamic intervention is currently a rule based on the presence of mechanical
ventilation each day
my.ltmle.contrast <- function(time, treatment, adjusted, sl) {
d.time <- pick_data(time)
n <- nrow(d.time$d)
abar.static.0 <- rep(0, time)
if (identical(treatment, "dynamic")) {
### dynamic 1: mech vent ######
abar.1 <- as.matrix(d.time$d[, paste0("L4.", 0:(time - 1))])
intervene.time <- 1:time
} else {
set.to.1 <- if (treatment$day <= time) treatment$day:time else NULL
if (treatment$delay) {
intervene.time <- set.to.1
} else {
intervene.time <- 1:time
}
### static or delayed: intervention starts on day
abar.1 <- matrix(0, nrow = n, ncol = time)
abar.1[, set.to.1] <- 1
}
abar.1.subset <- abar.1[, intervene.time, drop = FALSE]
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if (adjusted) {
my.qform <- qform.generate(time)
my.gform.0 <- gform.generate(time)
my.gform.1 <- my.gform.0[intervene.time]
} else {
my.qform <- qform.generate.unadjusted(time) # intercept only for Q
my.gform.0 <- matrix(0, nrow=n, ncol=time) #set P(A=0)=1; unadjusted estimates
are reported by setting the g matrix to 1s
my.gform.1 <- abar.1.subset
}
result.list <- list()
for (gcomp in c(FALSE, TRUE)) {
# run ltmle for control (always static)
result.0 <- ltmle(d.time$d, Anodes=d.time$my.A.nodes, Lnodes=d.time$my.L.nodes,
Ynodes=d.time$my.Y.nodes, abar=abar.static.0, SL.library=sl, estimate.time=
FALSE, survivalOutcome=TRUE, variance.method=’ic’,deterministic.Q.function=
my.det.Q.fun,gform=my.gform.0,Qform=my.qform, gcomp=gcomp)
# run ltmle for treated
result.1 <- ltmle(d.time$d, Anodes=d.time$my.A.nodes[intervene.time], Lnodes=d.
time$my.L.nodes, Ynodes=d.time$my.Y.nodes, abar=abar.1.subset, SL.library=sl
, estimate.time=FALSE, survivalOutcome=TRUE, variance.method=’ic’,
deterministic.Q.function=my.det.Q.fun,gform=my.gform.1, Qform=my.qform[
intervene.time], gcomp=gcomp)
result.list <- c(result.list, GetAllResults(result.0, result.1, gcomp))
}
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return(result.list)
}
GetConfInt <- function(result, estimator) {
c(summary(result, estimator)$treatment$estimate, summary(result, estimator)
$treatment$CI)
}
GetResults <- function(result.0, result.1, estimator) {
x <- list(GetConfInt(result.0, estimator), GetConfInt(result.1, estimator))
names(x) <- paste("est", c("ctrol", "tr"), estimator, sep = ".")
return(x)
}
GetAllResults <- function(result.0, result.1, gcomp) {
if (gcomp) {
GetResults(result.0, result.1, "gcomp")
} else {
c(GetResults(result.0, result.1, "tmle"), GetResults(result.0, result.1, "iptw
"))
}
}
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